Colorectal cancer: a tale of two sides or a continuum?: Figure 1
Abstract
Colorectal cancer comprises a heterogeneous group of diseases that arise through varying molecular carcinogenic pathways, involving complex interactions between tumour cells and the host microenvironment.1 2 It has long been appreciated that developmental and physiological differences exist between anatomic segments of the colorectum, and that colorectal cancers occur with distinctly different frequencies at different subsites.3 While approaches to surgical and adjuvant therapy have set rectal cancer as a separate entity, colon cancers still tend to get grouped together.Keywords
This publication has 53 references indexed in Scilit:
- The CpG island methylator phenotype in colorectal cancer: Progress and problemsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012
- Bacterial biogeography of the human digestive tractScientific Reports, 2011
- Epigenetics and colorectal cancerNature Reviews Gastroenterology & Hepatology, 2011
- Cancer immunology—analysis of host and tumor factors for personalized medicineNature Reviews Clinical Oncology, 2011
- One Colon Lumen but Two OrgansGastroenterology, 2011
- Personalized Colon Cancer Care in 2010Seminars in Oncology, 2011
- Sex disparities in colorectal cancer incidence by anatomic subsite, race and ageInternational Journal of Cancer, 2011
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trialsThe Lancet, 2010
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- Are there two sides to colorectal cancer?International Journal of Cancer, 2002